Hagerty: Growth Is Real, But The Post-Earnings Rally Stretches The Valuation

Hagerty (NYSE: HGTY) surged 18% in the five trading sessions following its Q2 2026 earnings release, closing at $13.61 and pressing against its 52-week high of $14. The rally makes sense at first glance: written premium grew 19%, adjusted EBITDA jumped 32%, and management raised full-year guidance. The operating engine is running.

The question the price move raises is whether the stock has already priced in the next two years of improvement. At a $4.7 billion market cap, the valuation bridge between current proof and future expectation has narrowed. I'm leaning to Hold at these levels. The business deserves its run — the entry point just needs to improve.

The Accounting Change That Makes The Top Line Look Broken

GAAP revenue fell 6.5% year-over-year to $354.8 million in Q2. Diluted EPS swung to a $0.02 loss from $0.09 a year ago. Taken at face value, that is a contraction. It is not.

The decline is an artifact of the Markel fronting arrangement that went live on January 1, 2026. Hagerty now retains 100% of the premium and risk on the Essentia book, rather than acting as a managing general agent earning commission revenue on risks it did not carry. The old model bookended $437 million in annual commission revenue against $344 million in ceding commission expense. Those line items disappear under the new structure. Revenue shrinks. Underlying economics improve.

Management's adjusted EBITDA — earnings before interest, taxes, depreciation, and amortization, a rough proxy for cash operating profit — grew 3% year-over-year in Q2 to $75 million and 32% for the first half to $160 million. That is the operating trend the accounting change obscures.

What Actually Carries The Growth Story

Three underlying metrics matter more than the GAAP revenue print.

Written premium grew 19% to $425 million in Q2, accelerating from 14% growth in the prior year. H1 written premium reached $713 million at the same 19% clip. Earned premium — the portion of written premium that is actually recognized as revenue as policies earn over time — surged 42% to $252 million, reflecting both new business and the higher quota share from the Markel transition.

Membership growth is the feedstock for that premium. Hagerty added a record 279,000 new members in the first half, bringing total Drivers Club paid members to over 962,000, a 6% year-over-year increase. Policies in force grew 19% to 1.9 million. Vehicles in force crossed the 3 million mark.

The marketplace business is accelerating too. Marketplace revenue jumped 48% to $40 million in Q2. Broad Arrow auctions posted 111% growth in aggregate sales to $104.4 million with a 91% sell-through rate. This segment is still small against the insurance base, but it represents a recurring revenue stream that does not carry underwriting risk.

Underwriting Discipline Still Holds

The Hagerty Re combined ratio (the sum of loss ratio and expense ratio; below 100% means the insurance operation is profitable) came in at 89.6% in Q2 and 88% for the first half. The loss ratio was 42.7% in Q2 and 40.6% for H1, down from 42.2% a year ago. That is better than most specialty lines.

Management attributes this to 40 years of proprietary loss data across 48,000 vehicle makes and models — a moat that does not exist for competitors entering the collector car space. The 50-basis-point decline in policy retention from 88.7% to 88.2% is worth watching. Management blamed the new, younger State Farm conversion book and minor softening in the core. Both are within historical range, but retention is the first metric that cracks when the enthusiast economy cools.

The GAAP Mess And When It Clears

Reported profitability is distorted by $199 million in 2026 transitional costs — amortization of deferred ceding commissions Hagerty paid to Markel for pre-transition policies. These costs are front-loaded: roughly $90 million in Q1, expected to drop to $37 million in Q3 and $9 million in Q4 as 2025 policies expire. On top of that, $57 million in acquisition expenses are being capitalized rather than expensed, adding another layer of non-cash accounting that will normalize as those costs amortize.

The upshot: 2026 GAAP net income is guided to $18–30 million. A $24 million midpoint on a $4.7 billion market cap produces a forward P/E of roughly 195x. That number is useless. It conflates one-time amortization with operating performance.

2027 is the clean year. Transition costs drop off. DAC amortization normalizes. Management won't give formal 2027 guidance yet, but indicated adjusted EBITDA growth should track written premium growth in the mid-teens.

Valuation: The Bridge Has Narrowed

This is where the rating shifts from Buy to Hold. The business is strong enough to earn its premium. The multiple is just doing a lot of the work already.

Using guided full-year adjusted EBITDA of $270–280 million, the enterprise value of $4.6 billion implies roughly 16.5–17x forward adjusted EBITDA. That is a fair multiple for a company growing mid-teens with strong cash conversion — but it is a fair multiple only if that growth actually materializes and margins don't compress.

Free cash flow is the strongest part of the case. Operating cash flow grew 91% to $186 million in the first half, and trailing-twelve-month free cash flow sits at $278.5 million. On that basis, the EV/FCF multiple is 16.5x. Hagerty carries $298 million in unrestricted cash against $216 million in total debt. The balance sheet is clean.

But the stock has moved from $9.36 at its 52-week low to $13.61 — a 45% run — in a matter of months, with the last 18% coming in five days. Multiple expansion, not just earnings growth, has done heavy lifting. At the current price, there is limited room for error in retention, loss ratio, or the State Farm conversion timeline.

The Catalyst Clock

The State Farm partnership is the largest single driver. Hagerty is converting 500,000+ existing State Farm collector car policies, with 14–15 states currently in the conversion phase and full integration expected by 2028. New policies are already being sold through State Farm agents in 37 states. That pipeline is real and underpins the 19% premium growth.

The Bennetts acquisition (UK motorcycle insurance, £34 million) triples Hagerty's scale in the UK and adds international diversification. Progressive expanded coverage to vehicles 25 years and older, adding 17 new vehicle cohorts. Liberty Mutual partnership is live. These are incremental, not transformative.

Q3 and Q4 provide the next test. The $57 million acquisition expense capitalization benefit drops to $15 million in the second half, and vanishes in Q4 as new policy season costs amortize. That means adjusted EBITDA growth in the back half may slow even if premium growth holds. If Q3 premium growth decelerates below 16%, the growth narrative takes a hit.

Risks

• Retention softening: 88.2% is still strong but trending down. The State Farm conversion book is younger and historically higher-churn.
• Loss ratio creep: 40.6% for H1 is comfortable but collector car claims are idiosyncratic. A single severe weather season or a spike in agreed-value claims can move the ratio quickly.
• 2027 uncertainty: Management declined to give formal 2027 guidance. If the "clean" year does not deliver the margin expansion investors are assuming, the forward multiple contracts.
• Concentration: Insurance is still the overwhelming revenue driver. Marketplace, membership, and digital services are growing but together represent a small fraction of the revenue base.

Takeaway

Hagerty's growth story is legitimate. The Markel transition was painful on paper but structurally sound.Premium growth is accelerating, underwriting discipline holds, free cash flow is strong, and the partner pipeline provides visible volume through 2028. This is not a name to short.

But the stock has rallied 18% in five days and is trading at 16.5–17x forward adjusted EBITDA with 45% of its upside from the 52-week low already realized. The valuation bridge between what is proven and what is expected is thin. I'd wait for a pullback toward the $11–12 range — the zone where the multiple again gives room for execution risk — before adding. At $13.61, Hold.